Selected article for: "day day and previous day"

Author: Yang Xu; Yi-rong Li; Qiang Zeng; Zhi-bing Lu; Yong-zhe Li; Wei Wu; Sheng-yong Dong; Gang Huang; Xing-huan Wang
Title: Clinical Characteristics of SARS-CoV-2 Pneumonia Compared to Controls in Chinese Han Population
  • Document date: 2020_3_10
  • ID: glq0lckz_22
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.08.20031658 doi: medRxiv preprint 9 lymphocytes were 0.8(IQR, 0.6-1.1)10 9 /L in Wuhan, 1.0(IQR, 0.7-1.4)10 9 /L in Beijing, and 1.1 (IQR, 0.8-1.5) 10 9 /L in Shanghai before admission to hospitals, respectively, indicating that cellular immune function related to the severity of disease. Our previous report shows that neutrophils increas.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.08.20031658 doi: medRxiv preprint 9 lymphocytes were 0.8(IQR, 0.6-1.1)10 9 /L in Wuhan, 1.0(IQR, 0.7-1.4)10 9 /L in Beijing, and 1.1 (IQR, 0.8-1.5) 10 9 /L in Shanghai before admission to hospitals, respectively, indicating that cellular immune function related to the severity of disease. Our previous report shows that neutrophils increase in non-survivors on day 11 and day 17, whereas, lymphocytes decrease in non-survivors on day 11 and day 17 significantly (p < 0.05) indicating cellular immunity related to mortality. 14 In 69 patients, there was an asymptomatic case in admission and the patient developed symptom 3 days after positive RT-PCR test.

    Search related documents:
    Co phrase search for related documents
    • admission asymptomatic case and disease severity: 1
    • admission asymptomatic case and hospital admission: 1
    • asymptomatic case and disease severity: 1, 2, 3, 4
    • asymptomatic case and hospital admission: 1, 2, 3, 4, 5, 6, 7
    • asymptomatic case and positive RT PCR test: 1, 2, 3, 4
    • asymptomatic case and RT PCR test: 1, 2, 3, 4, 5, 6
    • cellular immunity and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cellular immunity and hospital admission: 1
    • cellular immunity and immune function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • cellular immunity and lymphocyte decrease: 1, 2, 3
    • cellular immunity and positive RT PCR test: 1
    • cellular immunity and previous report: 1
    • cellular immunity and RT PCR test: 1, 2, 3
    • disease severity and immune function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease severity and lymphocyte decrease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • disease severity and mortality relate: 1, 2, 3
    • disease severity and non survivor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • disease severity and positive RT PCR test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • disease severity and previous report: 1, 2, 3, 4, 5